Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Thomas J George, MD, FACP, FASCO : Research

Cancer Specialist (Oncologist), Hematology and Oncology Specialist

Photo of Thomas J George

Research at a glance

Top areas of exploration

  • Pancreatic Neoplasms , 24 publications
  • Colorectal Neoplasms , 18 publications
  • Neoplasms , 17 publications
  • Adenocarcinoma , 12 publications

Research activity

215 publications

3,239 citations

Why is this important?

Focus

Clinical research in gastrointestinal malignancies is a primary aspect of Dr. George’s academic interests.  Specific areas of focus include active participation and development of clinical trials to promote novel drug application in patient care, quality of life/cancer care decision making, and identification of predictive markers for individualized therapy.  He has been a 10 year Gubernatorial appointee to the Executive Committee and immediate past Chair of the Florida Cancer Control and Research and Advisory Council which advises the legislature on matters related to cancer care and research in the state. He is a dedicated mentor and teacher of fellows, residents, and students in the College of Medicine and junior faculty both at UF and other major institutions.

Experimental Therapeutics - Dr. George is involved as a Principle Investigator in numerous clinical trials aimed at determining the optimal treatment for patients with gastrointestinal malignancies and bringing new therapies to patients with advanced cancers.  Collaboration includes numerous national clinical trial groups as well as the National Cancer Institute.  Representative protocols include studies in colon, rectal, pancreatic, esophagogastric, hepatobiliary and other treatment refractory cancers.  These novel therapies offer patients access to new treatments and hold the promise of becoming the next breakthrough in cancer patient care. 

Personalized Oncology - As cancer care becomes more complex, focus on a tailored approach to individualized treatments which maximize benefit while minimizing risk is critical.  Research involving the identification of specific markers or elements of a patient or their cancer which will predict, in advance, response to a given therapy is an area of active investigation.  The incorporation of new molecular markers, gene expression profiling, and pharmacogenomics into clinical care will help to provide patients with truly personalized care. 

Quality of Life and Decision Making - Patients and their loved ones facing the new diagnosis of a cancer face a variety of potentially overwhelming treatment options and decisions.  Collaboration with behavioral scientists, communication experts, and others are helping to break down the complex process of decision making in an attempt to determine how best to deliver treatment options and maximize quality of life.

Mentoring the Next Generation of Oncologists - The next generation holds the keys to continuing the work currently ongoing in cancer biology, therapeutics, and patient care.  Cancer therapies and knowledge are constantly changing and medicine requires a lifelong commitment to education. Development of novel educational tools, training modules, advanced curricula, mentorship and sponsorship aimed at providing oncologists with the skills needed to practice state of the art medicine while maintaining the humanism and sensitivity required for being entrusted with the honor of caring for patients with cancer is an area of ongoing professional and research interest.

Active clinical trials

ROSANNA

This study will investigate whether short-term daily energy drink consumption results in an increase in hydrogen sulfide-producing bacteria in adults 18-40 years old.

Investigator
Thomas J George
Status
Accepting Candidates
Ages
18 Years - 40 Years
Sexes
All
A Study of ASP1002 in Adults for Treatment of Solid Tumors

ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how it is processed by and acts upon the body. This information will help find a suitable dose…

Investigator
Thomas J George
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

215 publications

2024

A point-of-care pilot randomized intervention to connect patients with cancer-induced financial toxicity to telehealth financial counseling.

Cancer causes & control : CCC

PubMed Publisher's site

2024

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).

BMC cancer

PubMed Publisher's site

2024

Genetic Testing for Cancer Risk and Perceived Importance of Genetic Information Among US Population by Race and Ethnicity: a Cross-sectional Study.

Journal of racial and ethnic health disparities

PubMed Publisher's site

2024

Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.

Journal of cachexia, sarcopenia and muscle

PubMed Publisher's site

2024

Identifying social determinants of health from clinical narratives: A study of performance, documentation ratio, and potential bias

Journal of Biomedical Informatics

Publisher's site